HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brachytherapy in cancer of the prostate: an historical perspective.

Abstract
Carcinoma of the prostate in the United States has increased dramatically in the last few years due to improved detection methods including prostatic specific antigen testing and transrectal ultrasound. More than half of all prostate cancers are discovered while still localized. Radical prostatectomy and definitive radiation are reserved for patients in good health, who have localized disease. Brachytherapy, with its inherent ability to deliver a high dose to an organ-confined tumor, while minimally irradiating the surrounding tissues, has successfully competed with external beam for the treatment of early prostatic tumors. Their respective role is constantly under scrutiny and re-evaluation to improve the accuracy of delivery of radiation. The present review focuses on the role of brachytherapy for treatment of early cancer of the prostate over the span of this century and its future in the next millennium.
AuthorsB S Hilaris
JournalSeminars in surgical oncology (Semin Surg Oncol) 1997 Nov-Dec Vol. 13 Issue 6 Pg. 399-405 ISSN: 8756-0437 [Print] United States
PMID9358586 (Publication Type: Historical Article, Journal Article)
Topics
  • Brachytherapy (history)
  • History, 20th Century
  • Humans
  • Male
  • Prostatic Neoplasms (history, radiotherapy)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: